Clinical Trial Update: Initiation and Titration of Amaryl [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on initiating and titrating Amaryl (glimepiride) for type 2 diabetes mellitus; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED